相关实验视频

Updated: May 30, 2025

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
09:16

Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation

Published on: June 26, 2018

7.5K

与阿尔茨海默病表型和MCI-AD转换相关的明显的CSFα-synuclein聚合概况

Yanfei Ding1, Lingbing Wang1, Jun Liu1

  • 1Department of Neurology and Institute of Neurology, Ruijin Hospital affiliated to the Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.

The journal of prevention of Alzheimer's disease
|January 25, 2025
PubMed
概括

大脑脊髓液 (CSF) 中的α-synuclein (α-Syn) 聚合与阿尔茨海默病 (AD) 中的tau病理有关. 不同的α-Syn形式提供了关于AD预后和进展的见解,α-Syn1预测MCI转换为AD.

关键词:
阿尔茨海默病的疾病阿尔茨海默病的疾病.大脑脊髓液中的脑脊液.轻度认知障碍 轻度认知障碍α-Synuclein 是一种蛋白质.

更多相关视频

A Technique for Serial Collection of Cerebrospinal Fluid from the Cisterna Magna in Mouse08:08

A Technique for Serial Collection of Cerebrospinal Fluid from the Cisterna Magna in Mouse

Published on: November 10, 2008

101.4K
Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

10.7K

相关概念视频

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
9.2K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
439